FdaApplication

BLA 103795

Back to search

Identifiers

Properties

PropertyValue
applicant_nameImmunex Corporation
application_typeBLA
approval_date1998-11-02

Products (7)

ProductActive ingredientStrengthDosage form
ENBRELETANERCEPT25MGVIAL;SUBCUTANEOUS
ENBRELETANERCEPT25MGFor Injection
ENBREL—50MG/MLInjection
ENBREL—25MG/0.5MLInjection
ENBREL—25MG/0.5MLInjection
ENBREL—50MG/MLInjection
ENBREL MINI—50MG/MLInjection

7 products